AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11023194 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoral interferon-gamma (IFN-gamma) retroviral vector, multiple injections.
Number of subjects: 17
Study 9376465 — intervention group
Group type: EXPERIMENTAL
Intervention: Metamizol (1 g/100 ml NaCl 0.9% intravenously over 15 min) plus diclofenac (100 mg suppository) administered before induction and repeated at 6 h and 12 h.
Number of subjects: 74
Study 9376465 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not explicitly detailed in the abstract).
Number of subjects: 74
Study 8368464 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg once daily)
Number of subjects: 30
Study 8368464 — intervention group
Group type: COMPARATOR
Intervention: Terfenadine (60 mg twice daily)
Number of subjects: 30
Study 3010626 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (Ro 21-3981) at 0.2 mg . kg‐1
Number of subjects: 90
Study 3010626 — intervention group
Group type: COMPARATOR
Intervention: Diazepam at 0.3 mg . kg‐1
Number of subjects: 90
Study 31592880 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid training system with walking
Number of subjects: 28
Study 31592880 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 28
Study 29580238 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) treatment for SAM
Number of subjects: 934
Study 29580238 — intervention group
Group type: COMPARATOR
Intervention: Traditional facility-based treatment for SAM
Number of subjects: 934
Study 27751762 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of losartan (angiotensin-receptor blocker) for 3 days
Number of subjects: 14
Study 27751762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 25170262 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral medicine in physical therapy intervention
Number of subjects: 23
Study 25170262 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 23
Study 22371040 — intervention group
Group type: EXPERIMENTAL
Intervention: Fabric-based biopsy
Number of subjects: 55
Study 22371040 — intervention group
Group type: COMPARATOR
Intervention: Conventional biopsy (punch biopsy, sharp endocervical curettage)
Number of subjects: 55
Study 19583779 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated epilepsy patients
Number of subjects: 155
Study 19583779 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 155
Study 18375982 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (At) strategy
Number of subjects: 0
Study 18375982 — intervention group
Group type: COMPARATOR
Intervention: Verapamil-SR (Ve) strategy
Number of subjects: 0
Study 16002806 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (500 mg Ca/d for 1 year)
Number of subjects: 113
Study 16002806 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 113
Study 12468439 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose fluticasone propionate (500 microg twice a day)
Number of subjects: 30
Study 12468439 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose fluticasone propionate (100 microg twice a day)
Number of subjects: 30
Study 12468439 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (8 subjects)
Number of subjects: 30
Study 10337856 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitostanol ester-rich margarine (campestanol to sitostanol ratio 1:11)
Number of subjects: 23
Study 10337856 — intervention group
Group type: EXPERIMENTAL
Intervention: Campestanol ester-rich margarine (campestanol to sitostanol ratio 1:2)
Number of subjects: 23
Study 10337856 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitostanol ester-rich butter (campestanol to sitostanol ratio 1:13)
Number of subjects: 23
Study 10337856 — intervention group
Group type: COMPARATOR
Intervention: Control (butter period)
Number of subjects: 23
Study 8750370 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous TCA (2 mg as phosphate ester)
Number of subjects: 0
Study 8750370 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral TCA (5 mg)
Number of subjects: 0
Study 8750370 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled TCA (2 mg)
Number of subjects: 0
Study 2345211 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite resin restoration
Number of subjects: 40
Study 2345211 — intervention group
Group type: COMPARATOR
Intervention: Amalgam restoration
Number of subjects: 40
Study 7408529 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg diflunisal twice daily
Number of subjects: 52
Study 7408529 — intervention group
Group type: COMPARATOR
Intervention: 500 mg mefenamic acid three times daily
Number of subjects: 52
Study 31987558 — intervention group
Group type: EXPERIMENTAL
Intervention: MAX (maximal hopping group)
Number of subjects: 56
Study 31987558 — intervention group
Group type: COMPARATOR
Intervention: NAT (natural hopping group)
Number of subjects: 56
Study 31987558 — intervention group
Group type: COMPARATOR
Intervention: No stretch, 30 s stretch, multiple (4×) 30 s stretch, and dynamic stretch (treatment conditions)
Number of subjects: 56
Study 31429023 — intervention group
Group type: EXPERIMENTAL
Intervention: HTX-011
Number of subjects: 418
Study 28246237 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 3876
Study 28246237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3876
Study 25869658 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialysis yoga
Number of subjects: 31
Study 25869658 — intervention group
Group type: COMPARATOR
Intervention: Educational program
Number of subjects: 31
Study 25869658 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialysis yoga and Educational program
Number of subjects: 31
Study 24279841 — intervention group
Group type: EXPERIMENTAL
Intervention: GET.ON‐Mood Enhancer‐WL (web-based guided self-help intervention) in addition to treatment as usual (TAU)
Number of subjects: 200
Study 24279841 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 200
Study 21431880 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance-trained (Tr)
Number of subjects: 20
Study 21431880 — intervention group
Group type: COMPARATOR
Intervention: Untrained (UTr)
Number of subjects: 20
Study 21431880 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 19615830 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence Contingent (AC) group, n=35
Number of subjects: 68
Study 19615830 — intervention group
Group type: COMPARATOR
Intervention: Yoked Control (YC) group, n=33
Number of subjects: 68
Study 17580512 — intervention group
Group type: COMPARATOR
Intervention: Traditional fixed appliances
Number of subjects: 12
Study 17580512 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthotropic treatment (growth guidance)
Number of subjects: 12
Study 15611487 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture (23 sessions over 26 weeks)
Number of subjects: 570
Study 15611487 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (23 sessions over 26 weeks)
Number of subjects: 570
Study 15611487 — intervention group
Group type: COMPARATOR
Intervention: Education (6 two-hour sessions over 12 weeks)
Number of subjects: 570
Study 15767953 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine aerosols (4 mls of morphine sulphate nebulised 4 hourly)
Number of subjects: 12
Study 15767953 — intervention group
Group type: COMPARATOR
Intervention: Normal saline aerosols (4 mls of normal saline nebulised 4 hourly)
Number of subjects: 12
Study 10024851 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-choice-compatible condition (females)
Number of subjects: 24
Study 10024851 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-choice-compatible condition (males)
Number of subjects: 24
Study 10024851 — intervention group
Group type: COMPARATOR
Intervention: Overall reaction time advantage
Number of subjects: 24
Study 7736406 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU)/interferon alfa-2A (IFN-alpha)
Number of subjects: 30
Study 7736406 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU)/leucovorin
Number of subjects: 30
Study 7736406 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU) alone
Number of subjects: 30
Study 2293252 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine 75mg
Number of subjects: 14
Study 2293252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 7363639 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 267
Study 7363639 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin
Number of subjects: 267
Study 30581100 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT + CT
Number of subjects: 24
Study 28744114 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 21
Study 28744114 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 21
Study 28744114 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Training (PT) and Resistance Training (RT)
Number of subjects: 21
Study 28744114 — intervention group
Group type: COMPARATOR
Intervention: Control Session (CS)
Number of subjects: 21
Study 27208378 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (group and individual counseling)
Number of subjects: 319
Study 27208378 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (control group)
Number of subjects: 319
Study 23148779 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonceramic hydroxyapatite (ncHA)
Number of subjects: 11
Study 23148779 — intervention group
Group type: COMPARATOR
Intervention: Intraoral autogenous bone graft
Number of subjects: 11
Study 22768848 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge planning therapies primarily within the home environment
Number of subjects: 400
Study 22768848 — intervention group
Group type: COMPARATOR
Intervention: In-hospital consultation
Number of subjects: 400
Study 19361594 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxus stent implantation
Number of subjects: 74
Study 19361594 — intervention group
Group type: COMPARATOR
Intervention: Cypher stent implantation
Number of subjects: 74
Study 17586374 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior-hinged LASIK flap
Number of subjects: 33
Study 17586374 — intervention group
Group type: COMPARATOR
Intervention: Temporal-hinged LASIK flap
Number of subjects: 33
Study 16342002 — intervention group
Group type: EXPERIMENTAL
Intervention: N,N-dimethyltryptamine (DMT)
Number of subjects: 15
Study 16342002 — intervention group
Group type: EXPERIMENTAL
Intervention: (S)-ketamine
Number of subjects: 15
Study 11932129 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidz with Leukemia: A Space Adventure CD-ROM
Number of subjects: 0
Study 11932129 — intervention group
Group type: COMPARATOR
Intervention: You and Leukemia book
Number of subjects: 0
Study 9819786 — intervention group
Group type: EXPERIMENTAL
Intervention: moexipril 7.5 mg, uptitrated to 15 mg or 15 mg/HCTZ 25 mg if necessary
Number of subjects: 116
Study 9819786 — intervention group
Group type: COMPARATOR
Intervention: atenolol 25 mg, uptitrated to 50 mg or 50 mg/HCTZ 25 mg if necessary
Number of subjects: 116
Study 9819786 — intervention group
Group type: EXPERIMENTAL
Intervention: moexipril
Number of subjects: 116
Study 9819786 — intervention group
Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 116
Study 9819786 — intervention group
Group type: EXPERIMENTAL
Intervention: moexipril and atenolol
Number of subjects: 116
Study 7659476 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccines
Number of subjects: 2200
Study 7659476 — intervention group
Group type: COMPARATOR
Intervention: Whole-cell vaccine (WCL)
Number of subjects: 2200
Study 31881390 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation
Number of subjects: 0
Study 31881390 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 29097974 — intervention group
Group type: EXPERIMENTAL
Intervention: Information processing strategy training (PRPP System of Intervention and 4QM), 50 minutes per session, twice a week for 6 weeks
Number of subjects: 20
Study 29097974 — intervention group
Group type: COMPARATOR
Intervention: Traditional intervention, twice a week for 6 weeks
Number of subjects: 20
Study 27234609 — intervention group
Group type: EXPERIMENTAL
Intervention: Stand-alone cage
Number of subjects: 58
Study 27234609 — intervention group
Group type: COMPARATOR
Intervention: Bone autograft and plate implants
Number of subjects: 58
Study 24330156 — intervention group
Group type: EXPERIMENTAL
Intervention: NF3 (two-herb traditional Chinese medicine)
Number of subjects: 16
Study 24330156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 24330156 — intervention group
Group type: EXPERIMENTAL
Intervention: NF3
Number of subjects: 16
Study 22374985 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% saline nebulization
Number of subjects: 31
Study 22374985 — intervention group
Group type: COMPARATOR
Intervention: 7% saline nebulization
Number of subjects: 31
Study 19226381 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir 0.5 mg/day for 52 weeks
Number of subjects: 19
Study 19226381 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir 1.0 mg/day for 52 weeks
Number of subjects: 19
Study 19226381 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir 1.0 mg/day for additional 68-92 weeks
Number of subjects: 19
Study 19226381 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir treatment with annual liver biopsies
Number of subjects: 19
Study 19226381 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir treatment
Number of subjects: 19
Study 16451148 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (n=25)
Number of subjects: 51
Study 16451148 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (n=26)
Number of subjects: 51
Study 15197121 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral recumbent head-down position
Number of subjects: 450
Study 15197121 — intervention group
Group type: COMPARATOR
Intervention: Lateral recumbent horizontal position
Number of subjects: 450
Study 15197121 — intervention group
Group type: COMPARATOR
Intervention: Sitting position
Number of subjects: 450
Study 11726010 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with diuretics or beta-blockers (Group 1)
Number of subjects: 512
Study 11726010 — intervention group
Group type: COMPARATOR
Intervention: Treatment with calcium channel blockers or angiotensin-converting enzyme inhibitors (Group 2)
Number of subjects: 512
Study 9164833 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT+Ca (100 IU/day I.M. of SCT plus 1200 mg of elemental Ca for 10 days each month)
Number of subjects: 45
Study 9164833 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca (1200 mg of elemental Ca for 10 days each month)
Number of subjects: 45
Study 9164833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 7964696 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with progressive supranuclear palsy (PSP)
Number of subjects: 0
Study 7964696 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Parkinson's disease (PD)
Number of subjects: 0
Study 7964696 — intervention group
Group type: COMPARATOR
Intervention: Treatment with L-dopa in Parkinson's disease
Number of subjects: 0
Study 3609189 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled terbutaline (2 X 4 mg)
Number of subjects: 46
Study 3609189 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous adrenaline (2 X 0.5 mg)
Number of subjects: 46
Study 29571007 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF)
Number of subjects: 40
Study 27207526 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazoxide
Number of subjects: 15
Study 27207526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 25722360 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) for 6 weeks, weekly sessions.
Number of subjects: 0
Study 23916629 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Intervention (CBI)
Number of subjects: 25
Study 23916629 — intervention group
Group type: COMPARATOR
Intervention: Supportive Intervention (SI)
Number of subjects: 25
Study 20516379 — intervention group
Group type: EXPERIMENTAL
Intervention: cilostazol (100 to 200 mg/d)
Number of subjects: 329
Study 20516379 — intervention group
Group type: COMPARATOR
Intervention: aspirin (81 to 100 mg/d)
Number of subjects: 329
Study 19264451 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam XR 1000mg o.d.
Number of subjects: 24
Study 19264451 — intervention group
Group type: COMPARATOR
Intervention: Levetiracetam IR 500mg b.i.d.
Number of subjects: 24
Study 19264451 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam XR with food (1000mg single dose)
Number of subjects: 24
Study 19264451 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam XR (1000, 2000, and 3000mg)
Number of subjects: 24
Study 15723428 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic formulation of nizatidine 300 mg capsules
Number of subjects: 20
Study 15723428 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovator formulation of nizatidine 300 mg capsules
Number of subjects: 20
Study 15723428 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both formulations
Number of subjects: 20
Study 12612509 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 17
Study 12612509 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 17
Study 10681867 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion at acupoints such as Tianshu (St 25), Guanyuan (Ren 4)
Number of subjects: 62
Study 10681867 — intervention group
Group type: COMPARATOR
Intervention: Western drugs
Number of subjects: 62
Study 8760535 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary repair
Number of subjects: 109
Study 8760535 — intervention group
Group type: COMPARATOR
Intervention: Diversion (39 colostomies, 14 ileostomies)
Number of subjects: 109
Study 8760535 — intervention group
Group type: COMPARATOR
Intervention: Diversion
Number of subjects: 109
Study 1752926 — intervention group
Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotrophin (HCG) induced ovulation
Number of subjects: 48
Study 1752926 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous urinary luteinizing hormone (LH) surge
Number of subjects: 48
Study 6752877 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirprofen 200 mg
Number of subjects: 168
Study 6752877 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirprofen 400 mg
Number of subjects: 168
Study 6752877 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocin 100 mg
Number of subjects: 168
Study 6752877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 31449874 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein/low-carbohydrate hypocaloric diet (Diet HP)
Number of subjects: 270
Study 31449874 — intervention group
Group type: COMPARATOR
Intervention: Standard severe hypocaloric diet (Diet S)
Number of subjects: 270
Study 29183226 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone survey of parents regarding attendance for diagnostic tests
Number of subjects: 3239
Study 29183226 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for not attending diagnostic tests
Number of subjects: 3239
Study 29183226 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall attendance at the diagnostic level
Number of subjects: 3239
Study 26572756 — intervention group
Group type: EXPERIMENTAL
Intervention: Football training (FTG)
Number of subjects: 57
Study 26572756 — intervention group
Group type: COMPARATOR
Intervention: Standard care control (CON)
Number of subjects: 57
Study 24903067 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral wedged insoles (LWIs) - typical wedges
Number of subjects: 70
Study 24903067 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral wedged insoles (LWIs) - supported wedges
Number of subjects: 70
Study 24903067 — intervention group
Group type: COMPARATOR
Intervention: Control shoe
Number of subjects: 70
Study 23034077 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of feedback scales in the Partners for Change Outcome Management System (PCOMS)
Number of subjects: 75
Study 23034077 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 75
Study 18722743 — intervention group
Group type: EXPERIMENTAL
Intervention: SPOTI method
Number of subjects: 30
Study 18722743 — intervention group
Group type: COMPARATOR
Intervention: Traditional ACLS course
Number of subjects: 30
Study 17435410 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise
Number of subjects: 72
Study 17435410 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study 15144369 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including increasing self-efficacy to prevent falls, improving knowledge of medication safety, and decreasing environmental risks.
Number of subjects: 120
Study 15144369 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control).
Number of subjects: 120
Study 11553032 — intervention group
Group type: EXPERIMENTAL
Intervention: PD 123319 (8 microg/min)
Number of subjects: 0
Study 9623436 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibreoptic intubation
Number of subjects: 15
Study 9623436 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope with size 5 blade
Number of subjects: 15
Study 9623436 — intervention group
Group type: COMPARATOR
Intervention: Blind intubation with introducer
Number of subjects: 15
Study 7875184 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine 5 mg
Number of subjects: 18
Study 7875184 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine 15 mg
Number of subjects: 18
Study 7875184 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine 45 mg
Number of subjects: 18
Study 7875184 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine 60 mg
Number of subjects: 18
Study 7875184 — intervention group
Group type: EXPERIMENTAL
Intervention: Triprolidine 10 mg
Number of subjects: 18
Study 7875184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18